PHARMACOGENOMICS JOURNAL-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2021-02-07 122c3e01m19(暂无昵称)

已被下调为3区

93 0

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2019-12-09 ms9532643183630560

审稿速度:10.0
经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑

101 0

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2019-07-31 15736875548_88179330

请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表:
2018-11-02投稿，11-20under consideration，至今状态没有改变...
编辑部在03-27还专门发了一个致歉信...可爱

palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变...
编辑部在03-27还专门发了一个致歉信...可爱

138 0

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2019-05-19 930481735_75285775

我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表::
研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表:
2018-11-02投稿，11-20under consideration，至今状态没有改变...
编辑部在03-27还专门发了一个致歉信...可爱

palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱

143 0

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2019-04-23 palexander

审稿速度:6.0 | 投稿命中率:50.0
经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变...
编辑部在03-27还专门发了一个致歉信...可爱

147 0

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2017-01-19 helpwl

投了篇meta一审一个月多拒稿

308 0

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2011-06-29 匿名用户

偏重的研究方向：基因组学;

372 0

[GetPortalCommentsPageByObjectIdResponse(id=923519, encodeId=e1b29235198b, content=已被下调为3区, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6772357323, createdName=122c3e01m19(暂无昵称), createdTime=Sun Feb 07 18:20:46 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=855638, encodeId=7ea4855638a9, content=审稿速度:10.0 经验分享：这个杂志超级拖，文章被压了近八个月才送审，最后仅送了一个审稿人，修回后被拒，说是文章概念不新。本来就是写的一篇小综述，被拖了这么久，再新的概念都旧了。这个杂志神坑，希望能帮助大家避开。当然如果你时间多且完全不在意，也可以踩踩坑 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08165414055, createdName=ms9532643183630560, createdTime=Mon Dec 09 09:21:10 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574226, encodeId=372c5e422649, content=请问，后来的状态有什么变化吗？还是说under consideration就是under review的意思呀？谢谢palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=138, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01175151911, createdName=15736875548_88179330, createdTime=Wed Jul 31 00:00:00 CST 2019, time=2019-07-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=571171, encodeId=a9545e1171c3, content=我打算投药物基因组，会不会很热门呢 palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱palexander 2019-04-23 08:48:00 发表: 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=palexander 2019-04-23 发表:: 研究方向：药物基因组学;; 接收率：约50% 审稿时间：约6个月 2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, objectType=tool_impact_factor, channel=null, level=null, likeNumber=143, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ee42570897, createdName=930481735_75285775, createdTime=Sun May 19 00:00:00 CST 2019, time=2019-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=569913, encodeId=20035699133d, content=审稿速度:6.0 | 投稿命中率:50.0 经验分享：2018-11-02投稿，11-20under consideration，至今状态没有改变... 编辑部在03-27还专门发了一个致歉信...可爱, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=27d381873, createdName=palexander, createdTime=Tue Apr 23 08:48:00 CST 2019, time=2019-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=532053, encodeId=30f353205381, content=投了篇meta一审一个月多拒稿, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=308, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/q7Hn9JgEyWzxibdfH1iayiaupBicIqfdlT7FnzRk2rID6AicJHZnaVMgYOzheIEJLPqgA2pHWRyP6xd3yabKo46AdVw/132, createdBy=d2071616805, createdName=helpwl, createdTime=Thu Jan 19 12:57:00 CST 2017, time=2017-01-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=478274, encodeId=74774e827475, content=偏重的研究方向：基因组学;, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=372, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=null, createdTime=Wed Jun 29 15:29:00 CST 2011, time=2011-06-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=473962, encodeId=79e14e39624e, content=不易啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=408, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=毛毛, createdTime=Sat Feb 26 20:25:00 CST 2011, time=2011-02-26, status=1, ipAttribution=)]

2011-02-26 毛毛

不易啊

408 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务